Impact of the radiation protection program requirement of ST-1 on the United States radiopharmaceutical industry.
International conference on the packaging and transportation of radioactive materials. Paris, FRA, 1998/05/10.
The 1996 Edition of IAEA ST-I contains a requirement that the transport of radioactive materials be covered by a Radiation Protection Program (RPP).
The U.S. radiopharmaceutical industry makes more than 3 million shipments of radioactive materials each year.
These shipments originate from manufacturing facilities and nuclear pharmacies.
Although some shipments are made by the manufacturer's personnel, many of these shipments are transported by small carriers that do not operate fixed facilities and do not have radiation protection professionals on staff.
Consequently, requiring a small carrier to write and implement a Radiation Protection Program is a costly and difficult requirement.
Until the changes brought on by the RPP requirement in ST-I, the radiation exposures and protection of transport workers were managed by passive controls built into the IAEA and local competent authority regulations.
Examples of these passive controls include maximum transport indices (TI) on packages, maximum number of transport indices in vehicles, and separation distances.
All of these passive controls were designed to limit radiation exposure to transport workers.
In the United States, most of the radiopharmaceutical shipments are handled by independent carriers and not by the manufacturers.
In other parts of the world, the manufacturer employs transport workers to deliver the radiopharmaceuticals. (...)
Mots-clés Pascal : Produit radioisotopique, Industrie pharmaceutique, Radioprotection, Programme sanitaire, Etats Unis, Amérique du Nord, Amérique, Transport, Exposition professionnelle, Homme, Médecine travail
Mots-clés Pascal anglais : Radiopharmaceuticals, Pharmaceutical industry, Radioprotection, Sanitary program, United States, North America, America, Transport, Occupational exposure, Human, Occupational medicine
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0105977
Code Inist : 002A08F04. Création : 16/11/1999.